Optimal Ranges
Clinical (NHS) Range
<130 mg/dL
mg/dL
Performance-Optimised Range
<90 mg/dL (longevity-optimised: <80 mg/dL)
mg/dL
The clinical range defines what is considered medically “normal” — broad enough to cover 95% of the population. The performance range reflects where research and clinical experience suggest most people feel and function at their best.
Why It Matters
Why ApoB matters for performance
ApoB is increasingly recognised as the single best predictor of cardiovascular risk — superior to LDL-C, total cholesterol, and even the TC:HDL ratio. The European Atherosclerosis Society recommends ApoB measurement for accurate cardiovascular risk assessment. Two people can have identical LDL-C numbers but very different ApoB levels (and very different risk) depending on their particle size distribution. For men focused on longevity, ApoB is the marker that bridges the gap between a standard cholesterol panel and actual arterial risk.
Symptoms
Signs your levels may be off
Low / Deficiency
- Very low ApoB is generally not clinically significant
- May indicate malabsorption or liver dysfunction in extreme cases
High / Excess
- No direct symptoms — elevated ApoB is a silent risk factor
- Associated with accelerated atherosclerosis
- Increased risk of heart attack and stroke
- Often accompanies metabolic syndrome and insulin resistance
Dietary Sources
Foods that support ApoB levels
Supplementation
Evidence-based supplementation
Omega-3 fish oil (2-4g EPA+DHA daily) reduces ApoB-containing particle count by lowering VLDL production. Plant sterols and stanols (2g/day) block cholesterol absorption and can reduce ApoB by 5-10%. Berberine (1,000-1,500mg daily in divided doses) has LDL-lowering effects comparable to low-dose statins in some studies — it upregulates LDL receptors. Citrus bergamot extract (500-1,000mg daily) has emerging evidence for LDL particle reduction. For significantly elevated ApoB (>130), lifestyle plus pharmaceutical intervention (statins) may be warranted — discuss with your GP.
Research
Key study
Apolipoprotein B and cardiovascular disease: biomarker and potential therapeutic target
Sniderman AD, Thanassoulis G, Glavinovic T, et al.
The Lancet (2019)
DOI: 10.1016/S0140-6736(19)32519-0Related Biomarkers
Related Guides
Test your ApoB levels
ApoB is included in the Helvy 50+ biomarker panel. Get your results in 5 days with a personalised protocol.
Order Your TestThis content is for educational purposes only and does not constitute medical advice. Your data suggests areas for optimisation, but any concerns should be discussed with a qualified healthcare professional. If your results flag values outside safe ranges, we recommend consulting your GP.